首页> 外文期刊>Microbial drug resistance: MDR : Mechanisms, epidemiology, and disease >Prevalence of Genes Involved in Colistin Resistance inAcinetobacter baumannii:First Report from Iraq
【24h】

Prevalence of Genes Involved in Colistin Resistance inAcinetobacter baumannii:First Report from Iraq

机译:参与Colistin抵抗的基因的患病率为b ann acter acter acter(伊拉克)第一次报告

获取原文
获取原文并翻译 | 示例
           

摘要

Background and Aim:Colistin is increasingly being used as a "last-line" therapy to treat infections caused by multidrug-resistant (MDR)Acinetobacter baumanniiisolates, when essentially no other options are available in these days. The aim of this study was to detect genes associated with colistin resistance inA. baumannii. Methods:One hundred twenty-one isolates ofA. baumanniiwere collected from clinical and environmental samples during 2016 to 2018 in Baghdad. Isolates were diagnosed asA. baumanniiby using morphological tests, Vitek-2 system, 16SrRNA PCR amplification, and sequencing. Antibiotic susceptibility test was carried out using disk diffusion method. Phenotypic detection of colistin resistance was performed by CHROMagar (TM) COL-APSE medium and broth microdilution method for the determination of the minimal inhibitory concentration. Molecular detection of genes responsible for colistin resistance inA. baumanniiwas performed by PCR. Results:Ninety-two (76%) of the 121A. baumanniiisolates were colistin resistant. Twenty-six (21.5%) of the 121 isolates showed positive growth on CHROMagarAcinetobacterbase for MDR. PCR detectedmcr-1,mcr-2, andmcr-3genes in 89 (73.5%), 78 (64.5%), and 82 (67.8%)A. baumanniiisolates, respectively. Seventy-eight (64.5%) of the 121 isolates harbored the integronintI2gene and 81 (66.9%) containedintI3gene. Moreover, 60 (49.6%) of the 121 isolates were positive for the quorum sensinglasIgene. Conclusion:The presence of a large percentage of colistin-resistantA. baumanniistrains in Baghdad may be due to the presence of mobile genetic elements, and it is urgent to avoid unnecessary clinical use of colistin.
机译:背景和目的:Colistin越来越多地被用作“最后一线”治疗,以治疗多药抗性(MDR)肺杆菌引起的感染,当时这些天基本上没有其他选择。本研究的目的是检测与菌根抗性有关的基因。 Baumannii。方法:一百二十一分离株。 Baumanniiwere在2016年至2018年在巴格达的临床和环境样品中收集。分离物被诊断为ASA。 Baumanniiby使用形态试验,Vitek-2系统,16srRNA PCR扩增和测序。使用盘扩散法进行抗生素敏感性测试。 Chromagar(TM)COL-APSE培养基和肉汤微量稀释方法进行Colistin抗性的表型检测,用于测定最小抑制浓度。分子检测对菌落抗性INA的基因。 Baumanniiwas由PCR进行。结果:121A的九十二(76%)。 BaumanniiIsolates是耐药素。二十六(21.5%)的121个分离物显示出MDR的Chromagaracetobasterbase阳性生长。 PCR检测模型-1,MCR-2,ANDMCR-3GgenE在89(73.5%),78(64.5%)和82(67.8%)a中。 Baumanniiisolates分别。七十八(64.5%)的121个分离物覆盖整合壬酮和81(66.9%)的含量3庚烯。此外,60(49.6%)的121个分离株对于仲裁感应性为阳性。结论:存在大百分比的Colistin抵抗力。巴格达的Baumanniistrains可能是由于流动遗传元素的存在,迫切需要避免不必要的临床使用Colistin。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号